Story perspectives

US-China Trade War Escalates: Tariffs Threaten Medicine Supply

2/9/2025

48 11

Summary

Story summary

The US-China trade war intensified as Trump imposed a 10% tariff on Chinese goods, leading to China's retaliatory tariffs on US products.
The American Hospital Association cautioned that tariffs may disrupt the supply of essential medicines, with China supplying nearly 30% of critical drug ingredients.
US pharmaceutical companies are partnering with Chinese firms, while the Biden administration is contemplating excluding biotechnology from investment restrictions.
Trump's transactional approach to China, shaped by the pandemic, leaves room for potential trade deal negotiations despite existing tariffs.

1 of 1

Story summary

The US-China trade war intensified as Trump imposed a 10% tariff on Chinese goods, leading to China's retaliatory tariffs on US products.
The American Hospital Association cautioned that tariffs may disrupt the supply of essential medicines, with China supplying nearly 30% of critical drug ingredients.
US pharmaceutical companies are partnering with Chinese firms, while the Biden administration is contemplating excluding biotechnology from investment restrictions.
Trump's transactional approach to China, shaped by the pandemic, leaves room for potential trade deal negotiations despite existing tariffs.